G20 Global Health Summit-United States of America

Examines the latest advancements in precision oncology, including genomic profiling, targeted therapies, immunotherapies, and personalized treatment approaches for various types of cancer. Discussions may delve into the challenges of implementing precision medicine in clinical practice, the role of liquid biopsies in cancer diagnosis and monitoring, and emerging biomarkers for predicting treatment response.